- Technical innovations
- Open Access
Anatomical liver segmentectomy 2 for combined hepatocellular carcinoma and cholangiocarcinoma with tumor thrombus in segment 2 portal branch
© Ishii et al; licensee BioMed Central Ltd. 2012
- Received: 9 September 2011
- Accepted: 25 January 2012
- Published: 25 January 2012
Hepatic resection is the only effective treatment for combined hepatocellular carcinoma and cholangiocarcinoma.
A 52-year-old man was preoperatively diagnosed with hepatocellular carcinoma in segment 2 with tumor thrombus in the segment 2 portal branch. Anatomical liver segmentectomy 2, including separation of the hepatic arteries, portal veins, and bile duct, enabled us to remove the tumor and portal thrombus completely. Modified selective hepatic vascular exclusion, which combines extrahepatic control of the left and middle hepatic veins with occlusion of left hemihepatic inflow, was used to reduce blood loss. A pathological examination revealed combined hepatocellular carcinoma and cholangiocarcinoma with tumor thrombus in the segment 2 portal branch. No postoperative liver failure occurred, and remnant liver function was adequate.
The separation method of the hepatic arteries, portal veins, and bile duct is safe and feasible for a liver cancer patient with portal vein tumor thrombus. Modified selective hepatic vascular exclusion was useful to control bleeding during liver transection. Anatomical liver segmentectomy 2 using these procedures should be considered for a patient with a liver tumor located at segment 2 arising from a damaged liver.
- anatomical segmentectomy 2
- portal vein tumor thrombus
- combined hepatocellular carcinoma and cholangiocarcinoma
- modified selective hepatic vascular exclusion
Combined hepatocellular carcinoma and cholangiocarcinoma (cHCC-CC) is an uncommon primary liver cancer subtype  and is difficult to correctly diagnose preoperatively. Most patients with cHCC-CC are preoperatively misdiagnosed with hepatocellular carcinoma (HCC) or cholangiocarcinoma (CC) including our present patient. Hepatic resection leads to improved survival in patients with cHCC-CC [2–5] or HCC with portal vein tumor thrombus (PVTT) [6, 7]. In patients with liver cirrhosis, extended liver resection for liver cancer is sometimes not feasible because of decreased liver functional reserve; therefore, anatomical segmentectomy or limited non-anatomical hepatectomy must be performed. We herein report an anatomical liver segmentectomy 2 surgical procedure successfully performed for a patient with cHCC-CC and PVTT in the segment 2 portal branch (P2) root arising from liver cirrhosis due to hepatitis B virus. The Brisbane 2000 terminology of liver anatomy and resections was used.
Operative and left hemihepatic vascular occlusion times were 419 and 92 min, and blood loss during the operation and liver dissection were 939 and 500 ml. No blood transfusions were required during or after operation.
The postoperative course was good, with peak levels of serum aspartate aminotransferase, alanine aminotransferase, and total bilirubin of 264 IU/L, 243 IU/L, and 1.6 mg/dl. A left portal vein thrombus was revealed by CT and ultrasonography on postoperative day 8; however, this thrombus disappeared with anti-coagulant therapy. He was discharged 17 days after surgery.
The World Health Organization  defined cHCC-CC as a rare tumor containing unequivocal elements of intimately admixed HCC and CC. This tumor is distinguished from separate HCC and CC arising within the same liver. Patients with cHCC-CC and HCC are clinicopathologically similar in average age at the time of diagnosis (i.e., 50-60 years old), with a male predominance, viral hepatitis, elevated α-fetoprotein, and liver cirrhosis [3, 4, 11], and clinicopathological features in our case were similar to the above data. It is difficult to make a differential diagnosis of cHCC-CC or HCC; however, therapeutic options for patients with these tumors are almost the same, and liver resection leads to improved survival for both tumors [2–7].
Because a liver tumor located in segment 2 with PVTT in P2 is thought to readily metastasize through the portal venous flow to segments 3 and 4, left hepatectomy is the first choice of treatment. Left lateral sectionectomy is the second choice because the tumor was close to the left hepatic vein. However, in patients with liver cirrhosis, the left lateral section hypertrophies, and left hepatectomy or left lateral sectionectomy are sometimes not feasible because of decreased liver functional reserve and the relatively large volume of the left hemiliver or left lateral section . In our case, the left hemiliver and left lateral section became large (45% and 41% of the total liver, respectively) and the ICG-R15 level was relatively high (24%). And we judged preoperatively that we can exfoliate the tumor from the left hepatic vein. Therefore, anatomical liver segmentectomy 2 rather than left hepatectomy or left lateral sectionectomy was selected because it optimizes the balance between oncological requirements and the need to spare functioning liver parenchyma. Although preoperative surgical planning was evaluated by two-dimensional CT in our case, we think that three-dimensional CT computer-assisted preoperative surgical planning may be helpful for anatomical liver segmentectomy 2 . In anatomical segmentectomy 2, transection of the glissonean pedicle that feeds segment 2  and intraoperative ultrasound-guided blunt compression of the segment 2 portal branch  have been reported; however, these techniques are not suitable in liver cancer patients with PVTT in the root of P2, including our patient. In such cases, complete removal of PVTT is extremely important to prevent early tumor recurrence; therefore, after A2, A3, P2, and umbilical and transverse portions of the left portal vein were separated, the liver was dissected, and PVTT was removed under direct vision. It is easy to ligate and divide the origin of P2 before liver transection; however, we think that it is safer and more certain to incise the origin of P2 and suture the stump of P2 after liver transection than before liver transection. This separation method could be adapted for segmentectomy 3 and segmentectomy 3 and 4 . Although several reports [16, 17] have demonstrated the feasibility and safety of laparoscopic anatomic resection based on three-dimensional CT images recently, we performed anatomical liver segmentectomy 2 by open surgery because laparoscopic approach to hepatic tumors remains a challenge, and the patient in present report underwent upper abdominal surgeries (splenectomy, partial gastrectomy, and cholecystectomy). Left hemihepatic vascular occlusion, limited to 30 min followed by 5 min of perfusion, is useful to prevent blood loss originating from hepatic inflow ; however, it is difficult to control retrograde bleeding from the left hepatic vein using this maneuver. Selective hepatic vascular exclusion (SHVE), which combines inflow vascular occlusion (Pringle maneuver) with extrahepatic control of the major hepatic veins, overcomes the drawbacks of backflow bleeding of the Pringle maneuver . In segmentectomy 2 or 3, modified selective hepatic vascular exclusion (m-SHVE), which combines extrahepatic control of the middle and left hepatic veins with left hemihepatic inflow occlusion, is sufficient to reduce both backflow and inflow bleeding. In our case, this m-SHVE procedure contributed to reduce bleeding during liver dissection and was not associated with hemodynamic changes. SHVE has been used in major liver resections to control intraoperative bleeding [19, 20]; however, this technique has not been reported and studied in anatomical liver segmentectomy 2, to our knowledge. Furthermore, although it is reported in previous publications that SHVE entails Pringle maneuver and extrahepaic clamping of major hepatic veins [19, 20], m-SHVE which entails not Pringle maneuver but hemihepatic inflow occlusion has not been reported. Therefore, anatomical liver segmentectomy 2 with m-SHVE is the novel technique. We think that this m-SHVE is the effective technique in anatomical liver segmentectomy 2 and can be adapted also for anatomical liver segmentectomy 3. Intraabdominal adhesion resulting from previous surgery was very severe, and then, about 120 min were required and blood loss was about 400 ml during exfoliation of this adhesion. Therefore, we think that the operative time (419 min) and the amount of blood loss (939 ml) in our case seem in the tolerance. The liver transection time was relatively longer because of the hard texture of liver parenchyma resulting from liver cirrhosis. Because postoperative liver function was adequate in our case, anatomical segmentectomy 2 is feasible to preserve remnant liver function in selected patients with liver cirrhosis.
Survival of patients with cHCC-CC was significantly poorer than that of HCC or CC patients [3–5], and the PVTT was found to be significant predictor of poor outcome [3, 5]. In our case, the patient is alive 9 months after surgery with lymph nodes metastasis. Although limited hepatectomy was performed, the patient has no recurrence in the remnant liver. Therefore, in selected patients with liver cirrhosis, limited hepetectomy including anatomical segmentectomy 2 may be an appropriate operation even if patients have the PVTT.
The hepatic arteries, portal veins, and bile duct separation method is a useful approach for a liver cancer patient with PVTT, and m-SHVE is effective for minimizing bleeding during liver resection of segmentectomy 2. Anatomical liver segmentectomy 2 contributes to preserve remnant liver function; however, further investigation is needed to evaluate the overall survival rates in patients who undergo segmentectomy 2.
Written informed consent was obtained from the patient for publication of his clinical details and accompanying images. A copy of the written consent is available for review by the Editor of this journal.
- Goodman ZD, Ishak KG, Langloss JM: Combined hepatocellular cholangiocarcinoma. A histologic and immunohistochemical study. Cancer. 1985, 55: 124-135. 10.1002/1097-0142(19850101)55:1<124::AID-CNCR2820550120>3.0.CO;2-Z.View ArticlePubMedGoogle Scholar
- Jarnagin WR, Weber S, Tickoo SK, Koea JB, Obiekwe S, Fong Y, DeMatteo RP, Blumgart LH, Klimstra D: Combined hepatocellular and cholangiocarcinoma: demographic, clinical, and prognostic factors. Cancer. 2002, 94: 2040-2046. 10.1002/cncr.10392.View ArticlePubMedGoogle Scholar
- Yano Y, Yamamoto J, Kosuge T, Sakamoto Y, Yamasaki S, Shimada K, Ojima H, Sakamoto M, Takayama T, Makuuchi M: Combined hepatocellular and cholangiocarcinoma: a clinicopathologic study of 26 resected cases. Jpn J Clin Oncol. 2003, 33: 283-287. 10.1093/jjco/hyg056.View ArticlePubMedGoogle Scholar
- Liu CL, Fan ST, Lo CM, Ng IO, Lam CM, Poon RT, Wong J: Hepatic resection for combined hepatocellular and cholangiocarcinoma. Arch Surg. 2003, 138: 86-90. 10.1001/archsurg.138.1.86.View ArticlePubMedGoogle Scholar
- Park H, Choi KH, Choi SB, Choi JW, Kim do Y, Ahn SH, Kim KS, Choi JS, Han KH, Chon CY, Park JY: Clinicopathological characteristics in combined hepatocellular-cholangiocarcinoma: a single center study in Korea. Yonsei Med J. 2011, 52: 753-760. 10.3349/ymj.2011.52.5.753.PubMed CentralView ArticlePubMedGoogle Scholar
- Lin DX, Zhang QY, Li X, Ye QY, Lin F, Li LL: An aggressive approach leads to improved survival in hepatocellular carcinoma patients with portal vein tumor thrombus. J Cancer Res Clin Oncol. 2011, 137: 139-149. 10.1007/s00432-010-0868-x.PubMed CentralView ArticlePubMedGoogle Scholar
- Minagawa M, Makuuchi M, Takayama T, Ohtomo K: Selection criteria for hepatectomy in patients with hepatocellular carcinoma and portal vein tumor thrombus. Ann Surg. 2001, 233: 379-384. 10.1097/00000658-200103000-00012.PubMed CentralView ArticlePubMedGoogle Scholar
- Liver Cancer Study Group of Japan: The general rules for the clinical and pathological study of primary liver cancer. 2003, Tokyo: Kanehara Press, 2nd EnglishGoogle Scholar
- Makuuchi M, Mori T, Gunven P, Yamazaki S, Hasegawa H: Safety of hemihepatic vascular occlusion during resection of the liver. Surg Gynecol Obstet. 1987, 164: 155-158.PubMedGoogle Scholar
- Wittekind C, Fischer HP, Ponchon T: Combined hepatocellular and cholangiocarcinoma. World Health Organization classification of tumours of the digestive system. Edited by: Hamilton SR, Aaltonen LA. 2000, Lyon: IARC Press, 181-Google Scholar
- Kim JH, Yoon HK, Ko GY, Gwon DI, Jang CS, Song HY, Shin JH, Sung KB: Nonresectable combined hepatocellular carcinoma and cholangiocarcinoma: analysis of the response and prognostic factors after transcatheter arterial chemoembolization. Radiology. 2010, 255: 270-277. 10.1148/radiol.09091076.View ArticlePubMedGoogle Scholar
- Sadamori H, Matsuda H, Shinoura S, Umeda Y, Yoshida R, Sato D, Utsumi H, Ohnishi H, Yagi T: Anatomical subsegmentectomy in the lateral segment for hepatocellular carcinoma. Hepatogastroenterology. 2009, 56: 1511-1515.PubMedGoogle Scholar
- Radtke A, Sotiropoulos GC, Molmenti EP, Schroeder T, Peitgen HO, Frilling A, Broering DC, Broelsch CE, Malago' M: Computer-assisted surgery planning for complex liver resections: When is it helpful? A single-center experience over an 8-year period. Ann Surg. 2010, 252: 876-883. 10.1097/SLA.0b013e3181fdd012.View ArticlePubMedGoogle Scholar
- Torzilli G, Makuuchi M: Ultrasound-guided finger compression in liver subsegmentectomy for hepatocellular carcinoma. Surg Endosc. 2004, 18: 136-139. 10.1007/s00464-003-9024-x.View ArticlePubMedGoogle Scholar
- Kawasaki S, Makuuchi M, Harada H, Takayama T, Kosuge T: A new alternative hepatectomy method for resection of segment 3 and 4 of the liver. Surg Gynecol Obstet. 1992, 175: 267-269.PubMedGoogle Scholar
- Mutter D, Dallemagne B, Bailey Ch, Soler L, Marescaux J: 3D virtual reality and selective vascular control for laparoscopic left hepatic lobectomy. Surg Endosc. 2009, 23: 432-435. 10.1007/s00464-008-9931-y.View ArticlePubMedGoogle Scholar
- Ueno S, Sakoda M, Kurahara H, Iino S, Minami K, Ando K, Mataki Y, Maemura K, Ishigami S, Takumi K, Fukukura Y, Natsugoe S: Preoperative segmentation of the liver, based on 3D CT images, facilitates laparoscopic anatomic hepatic resection for small nodular hepatocellular carcinoma in patients with cirrhosis. Hepatogastroenterology. 2010, 57: 807-812.PubMedGoogle Scholar
- Lau WY, Lai ECH, Lau SHY: Methods of vascular control technique during liver resection: a comprehensive review. Hepatobiliary Pancreat Dis Int. 2010, 9: 473-481.PubMedGoogle Scholar
- Fu SY, Lai EC, Li AJ, Pan ZY, Yang Y, Sun YM, Lau WY, Wu MC, Zhou WP: Liver resection with selective hepatic vascular exclusion: a cohort study. Ann Surg. 2009, 249: 624-627. 10.1097/SLA.0b013e31819ed212.View ArticlePubMedGoogle Scholar
- Zhou W, Li A, Pan Z, Fu S, Yang Y, Tang L, Hou Z, Wu M: Selective hepatic vascular exclusion and Pringle maneuver: a comparative study in liver resection. Eur J Surg Oncol. 2008, 34: 49-54. 10.1016/j.ejso.2007.07.001.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.